Skip to main content
. 2020 Nov 2;14:4703–4715. doi: 10.2147/DDDT.S266726

Table 8.

Anesthetic and Patient Factors Associated with Low/High cSO2

Anesthetic and Patient Factors Low cSO2 During Neonatal Transition Period, OR(95% CI) High cSO2 During Neonatal Transition Period, OR(95% CI)
Oxygen inhalation 2.1 (0.9–4.8) 0.9 (0.4–2.2)
Comorbidities 3.2 (1.5–7.0)** 3.4 (1.5–7.5)**
Anesthesia plane above T6 1.1 (0.3–4.9) 0.9 (0.9–1.0)
Vasoactive drug used before cord clamping 0.6 (0.3–1.4) 0.8 (0.3–1.9)
Maternal systolic BP below 74mmHg or diastolic BP below 40mmHg under IA 1.8 (0.4–8.1)
Maternal systolic BP above 143mmHg or diastolic BP above 90mmHg under IA 4.8 (1.8–12.5)**
Maternal SpO2 below 96% 3.0 (0.8–10.6)
Male sex (male/female) 0.3 (0.9–1.1) 2.0 (0.7–6.0)
ASA II vs I 3.8 (0.5–28.9) 1.9 (0.4–8.2)
ASA III vs I 21.0 (1.9–231.0)* 1.0 (0.9–1.0)
ASA III vs II 5.5 (1.3–22.4)* 1.1 (0.1–9.0)
Low arteriole pressure(SBP less than 35mmHg or DBP less than 11mmHg) 1.8 (0.5–6.1) 0.7 (0.3–2.1)
Low HR(less than 123 times/min) 3.0 (0.3–26.1) 1.6 (0.2–13.1)
Length of time from administration to cord clamping more than 17min 1.7 (0.2–14.1) 1.3 (0.2–10.8)
Existing problems with umbilical cord at birth 0.8 (0.2–3.9) 0.3 (0.0–2.2)
Neonatal THb less than 14.84g/dL 0.3 (0.1–1.3) 0.7 (0.2–2.2)
Neonatal Glu less than 3.78 mmol/L 0.7 (0.2–2.1) 2.1 (0.7–6.2)
Neonatal O2Hb less than 51.67% 1.7 (0.3–9.8) 1.4 (0.2–8.0)
Maternal THb less than 124.6g/L 1.2 (0.4–3.3) 0.5 (0.1–1.5)

Notes: **Data show statistical significance at P < 0.01; *Data show statistical significance at P < 0.05.